InsidersTradesSigma
Explore the detailed record of transactions filed by Burrows Scott L, Chief Financial Officer. Insider active across 1 companies, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €452k. The latest transaction was filed on 3 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Scott L. Burrows is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. He is responsible for the financial management of the company, including budgeting and financial strategy, to support the company's research and development goals.